Jiayue-Clara Jiang

Ms. Jiayue-Clara Jiang

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2019 in Mobile DNA
Verified
Journal Article
Open access
PDF file
JJJiayue-Clara Jiang
Jiayue-Clara Jiang
KUKyle R. Upton
Kyle R. Upton
Transposable elements (TE) are commonly regarded as “junk DNA” with no apparent regulatory roles in the human genome. However, a growing body of evidence demonstrates that some TEs exhibit regulatory activities in a range of biological pathways and diseases, with notable examples in bile metabolism and innate immunity. TEs are typically suppressed by epigenetic modifications in healthy somatic tissues, which prevents both undesirable effects of insertional mutagenesis, and also unwanted gene activation. Interestingly, TEs are widely reported to be dysregulated in epithelial cancers, and while much attention has been paid to their effects on genome instability, relatively little has been reported on their effects on gene regulation. Here, we investigated the contribution of TEs to the transcriptional regulation in breast cancer cell lines. We found that a subset of TE subfamilies were enriched in oncogenic transcription factor binding sites and also harboured histone marks associated with active transcription, raising the possibility of these subfamilies playing a broad role in breast cancer transcriptional regulation. To directly assess promoter activity in triple negative breast cancer cell lines, we identified four breast cancer-associated genes with putative TE-derived promoters. TE deletion confirmed a contribution to promoter activity in all cases, and for two examples the promoter activity was almost completely contained within the TE. Our findings demonstrate that TEs provide abundant oncogenic transcription factor binding sites in breast cancer and that individual TEs contain substantial promoter activity. Our findings provide further evidence for transcriptional regulation of human genes through TE exaptation by demonstrating the regulatory potential of TEs in multiple breast cancer cell lines.

1 December 2024 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Open access
JJJiayue-Clara Jiang
Jiayue-Clara Jiang
KSKritika Singh
Kritika Singh
RNRachana Nitin
Rachana Nitin
LDLea K. Davis
Lea K. Davis
NWNaomi R. Wray
Naomi R. Wray
SSSonia Shah
Sonia Shah
BACKGROUND: Though epidemiological studies show increased cardiovascular disease (CVD) risks among individuals with psychiatric disorders, findings on sex differences in comorbidity have been inconsistent. METHODS: This genetic epidemiology study examined the sex-specific association between the genetic risk of 3 psychiatric disorders (major depression [MD], schizophrenia, and bipolar disorder), estimated using polygenic scores (PGSs), and risks of 3 CVDs (atrial fibrillation [AF], coronary artery disease [CAD], and heart failure [HF]) in 345 169 European-ancestry individuals (UK Biobank), with analyses replicated in an independent BioVU cohort (n=49 057). Mediation analysis was conducted to determine whether traditional CVD risk factors could explain any observed sex difference. RESULTS: In the UK Biobank, a 1-SD increase in PGS MD was significantly associated with the incident risks of all 3 CVDs in females after multiple testing corrections (hazard ratio [HR] AF-female =1.04 [95% CI, 1.02–1.06]; P =1.5×10 − 4 ; HR CAD-female =1.07 [95% CI, 1.04–1.11]; P =2.6×10 − 6 ; and HR HF-female =1.09 [95% CI, 1.06–1.13]; P =9.7×10 − 10 ), but not in males. These female-specific associations remained even in the absence of any psychiatric disorder diagnosis or psychiatric medication use. Although mediation analysis demonstrated that the association between PGS MD and CVDs in females was partly mediated by baseline body mass index, hypercholesterolemia, hypertension, and smoking, these risk factors did not explain the higher risk compared with males. The association between PGS MD and CAD was consistent between females who were premenopausal and postmenopausal at baseline, while the association with AF and HF was only observed in the baseline postmenopausal cohort. No significant association with CVD risks was observed for the PGS of schizophrenia or bipolar disorder. The female-specific positive association of PGS MD with CAD risk was replicated in BioVU. CONCLUSIONS: Genetic predisposition to MD confers a greater risk of CVDs in females versus males, even in the absence of any depression diagnosis. This study warrants further investigation into whether genetic predisposition to depression could be useful for improving cardiovascular risk prediction, especially in women.

Verified
Journal Article
Open access
PDF file
JJJiayue-Clara Jiang
Jiayue-Clara Jiang
JRJoseph Rothnagel
Joseph Rothnagel
KUKyle R. Upton
Kyle R. Upton
L1 transposons occupy 17% of the human genome and are widely exapted for the regulation of human genes, particularly in breast cancer, where we have previously shown abundant cancer-specific transcription factor (TF) binding sites within the L1PA2 subfamily. In the current study, we performed a comprehensive analysis of TF binding activities in primate-specific L1 subfamilies and identified pervasive exaptation events amongst these evolutionarily related L1 transposons. By motif scanning, we predicted diverse and abundant TF binding potentials within the L1 transposons. We confirmed substantial TF binding activities in the L1 subfamilies using TF binding sites consolidated from an extensive collection of publicly available ChIP-seq datasets. Young L1 subfamilies (L1HS, L1PA2 and L1PA3) contributed abundant TF binding sites in MCF7 cells, primarily via their 5′ UTR. This is expected as the L1 5′ UTR hosts cis-regulatory elements that are crucial for L1 replication and mobilisation. Interestingly, the ancient L1 subfamilies, where 5′ truncation was common, displayed comparable TF binding capacity through their 3′ ends, suggesting an alternative exaptation mechanism in L1 transposons that was previously unnoticed. Overall, primate-specific L1 transposons were extensively exapted for TF binding in MCF7 breast cancer cells and are likely prominent genetic players modulating breast cancer transcriptional regulation.

4 April 2023 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
JJJiayue-Clara Jiang
Jiayue-Clara Jiang
CHChenwen Hu
Chenwen Hu
AMAndrew M. McIntosh
Andrew M. McIntosh
SSSonia Shah
Sonia Shah
Observational studies and randomized controlled trials presented inconsistent findings on the effects of cholesterol-lowering statins on depression. It therefore remains unclear whether statins have any beneficial effects on depression, and if so, what the underlying molecular mechanisms are. Here, we aimed to use genomic approaches to investigate this further. Using Connectivity Map (CMap), we first investigated whether statins and antidepressants shared pharmacological effects by interrogating gene expression responses to drug exposure in human cell lines. Second, using Mendelian randomization analysis, we investigated both on-target (through HMGCR inhibition) and potential off-target (through ITGAL and HDAC2 inhibition) causal effects of statins on depression risk and depressive symptoms, and traits related to the shared biological pathways identified from CMap analysis. Compounds inducing highly similar gene expression responses to statins in HA1E cells (indicated by an average connectivity score with statins > 90) were found to be enriched for antidepressants (12 out of 38 antidepressants; p = 9E-08). Genes perturbed in the same direction by both statins and antidepressants were significantly enriched for diverse cellular and metabolic pathways, and various immune activation, development and response processes. MR analysis did not identify any significant associations between statin exposure and depression risk or symptoms after multiple testing correction. However, genetically proxied HMGCR inhibition was strongly associated with alterations in platelets (a prominent serotonin reservoir) and monocyte percentage, which have previously been implicated in depression. Genetically proxied ITGAL inhibition was strongly associated with basophil, monocyte and neutrophil counts. We identified biological pathways that are commonly perturbed by both statins and antidepressants, and haematological biomarkers genetically associated with statin targets. Our findings warrant pre-clinical investigation of the causal role of these shared pathways in depression and potential as therapeutic targets, and investigation of whether blood biomarkers may be important considerations in clinical trials investigating effects of statins on depression.

25 February 2026 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
JJJiayue-Clara Jiang
Jiayue-Clara Jiang
CBCamille Brianceau
Camille Brianceau
EDElise Delzant
Elise Delzant
RCRomain Colle
Romain Colle
HBHugo Bottemanne
Hugo Bottemanne
BCBaptiste Couvy-Duchesne
Baptiste Couvy-Duchesne
The accuracy of grey-matter predictors of depression has remained limited. In this study, brain-based predictors of major depressive disorder (MDD) were trained using machine-learning (Best Linear Unbiased Predictors [BLUP]) and deep-learning (ResNet3D) techniques applied to high-dimensional (voxel-wise) grey-matter structure extracted from T1-weighted structural MRI. The training sample comprised 987 MDD cases and 3934 controls from the UK Biobank. Predictors were evaluated in an independent sub-cohort of 483 MDD cases and 1939 controls from the UK Biobank and replicated in a clinical cohort (DEP-ARREST CLIN) of 64 cases and 32 controls. In the UK Biobank, the BLUP predictor showed a significant association with MDD status (AUC = 0.57; OR = 1.28 [1.15-1.43]; p-value = 1.1×10 -5 ), which was confirmed in both males and females. By partitioning the BLUP predictor by brain regions of interest (ROI), we found nominal significance supporting the contribution of previously identified MDD-related ROIs (e.g. hippocampus and amygdala), though none passed multiple testing correction. The BLUP predictor overlapped partially with a polygenic score (PGS) of major depression (AUC = 0.65) but also captured a nominally significant signal that was not captured by the genetic score (combined AUC = 0.66, p-value = 0.024 when compared to PGS alone). No association passed multiple testing correction in the DEP-ARREST CLIN cohort, likely due to the small sample size. In contrast, the deep-learning predictor was not associated with MDD after multiple testing corrections. We estimated the morphometricity of MDD to be 0.061, implying limited potential of a brain-based predictor based on grey-matter structure (maximal AUC = 0.64). While the modest AUC values reiterate the challenge of developing brain-based MDD predictors for clinical applications, our predictors inform future research to explore brain-based relationships between MDD and comorbidities.

10 October 2022 in medRxiv
Verified
Preprint
Open access
PDF file
JJJiayue-Clara Jiang
Jiayue-Clara Jiang
KSKritika Singh
Kritika Singh
LDLea K. Davis
Lea K. Davis
NWNaomi R. Wray
Naomi R. Wray
SSSonia Shah
Sonia Shah
Background: The lack of research on female-specific risk factors for cardiovascular diseases (CVD) has led to sex-based disparities in cardiovascular health. Though epidemiological studies show increased CVD risks amongst individuals with psychiatric disorders, findings on sex differences in comorbidity have been inconsistent. Methods: This genetic epidemiology study examined the sex-specific association between the genetic risk of three psychiatric disorders [major depression (MD), schizophrenia and bipolar disorder], estimated using polygenic scores (PGS), and risks of three CVDs [atrial fibrillation (AF), coronary artery disease (CAD) and heart failure (HF)] in 345,169 European-ancestry individuals (UK Biobank), with analyses replicated in an independent BioVU cohort (N=49,057). Mediation analysis was conducted to determine whether traditional CVD risk factors could explain any observed sex difference. Results: In UK Biobank, PGS MD was significantly associated with the incident risks of all three CVDs in females after multiple testing correction [hazard ratio (HR) AF-female =1.04 (95% CI: 1.02-1.06; p=0.00015); HR CAD-female =1.07 (1.04-1.11; p=2.6E-06); HR HF-female =1.09 (1.06-1.13; p=9.7E-10)], but not in males. These female-specific associations remained even in the absence of any psychiatric disorder diagnosis or psychiatric medication use. Although mediation analysis demonstrated that the association between PGS MD and CVDs in females was partly mediated by baseline BMI, hypercholesterolemia, hypertension and smoking, these risk factors did not explain the higher risk compared to males. The association between PGS MD and CAD was consistent between females who were pre-menopausal and post-menopausal at baseline (mean baseline age of 44.9 and 60.8 years, respectively), while the association with AF and HF was only observed in the baseline post-menopausal cohort. No significant association with CVD risks was observed for the PGS of schizophrenia or bipolar disorder. The positive association of PGS MD with CAD and HF risk in females was replicated in BioVU, where the corresponding associations in males also reached nominal significance. Conclusions: Genetic predisposition to MD confers a greater risk of CVDs in females versus males, even in the absence of any depression diagnosis. This study warrants further investigation into whether genetic predisposition to depression could be useful for improving cardiovascular risk prediction even in the absence of a depression diagnosis, especially in women.